Home/Filings/4/0001241322-03-000003
4//SEC Filing

GTC BIOTHERAPEUTICS INC 4

Accession 0001241322-03-000003

CIK 0000904973operating

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 3:55 PM ET

Size

5.6 KB

Accession

0001241322-03-000003

Insider Transaction Report

Form 4
Period: 2003-09-26
MEADE HARRY
SVP, Transgenic Research
Transactions
  • Other

    Common Stock

    2003-09-26$2.34/sh+1,216$2,84234,226 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    7,916.317
  • Common Stock

    (indirect: By Son)
    653
Footnotes (2)
  • [F1]Shares acquired through Issuer's Employee Stock Purchase Plan, a Rule 16b-3 plan.
  • [F2]The reporting person disclaims beneficial ownership of 653 shares of common stock held indirectly by his adult son in his 401(k) Plan, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

Issuer

GTC BIOTHERAPEUTICS INC

CIK 0000904973

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000904973

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 3:55 PM ET
Size
5.6 KB